CVC  Action Potential Venture Capital

http://www.actionpotentialvc.com





     Office Locations:

One Broadway
Cambridge, MA 02142

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Medical Device

  •  

    Description:

    Action Potential Venture Capital is GlaxoSmithKline's (GSK) $50 million strategic venture capital fund created to invest in companies that are pioneering bioelectronic medicines and technologies. The fund will build a portfolio with five to seven companies over the next five years. The focus for investments will be in three main areas: new start-up companies that aim to pursue the vision of bioelectronic medicines; existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses; and companies advancing technology platforms that will underpin these treatment modalities.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Imran Eba Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/24/2018


      Neuspera Medical


      CA


      $26,000,000


      Series B


      08/28/2017


      SetPoint Medical


      CA


      $300,000,000


      Series D


     

    Portfolio companies include:


      CVRx
        web link


      Neuspera Medical
        web link


      SetPoint Medical
        web link


     

    Recent News:


      There is no recent news for Action Potential Venture Capital.